UncategorizedAltos Labs expands into senotherapeutics with Dorian acquisition – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedLongevity Investor Network doubles in size in 2024 – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedVivodyne lands $40m to replace animal testing in drug development Empower Meds / November 22, 2025
UncategorizedBioAge plots clinical trial of NLRP3 inhibitor this year Empower Meds / November 22, 2025
UncategorizedBioAge expands APJ agonist pipeline – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedHaya Therapeutics moves San Diego operations to Lilly Gateway Labs – Longevity.Technology Empower Meds / November 22, 2025
UncategorizedMagnitude Biosciences lands funding to accelerate longevity drug development Empower Meds / November 22, 2025
UncategorizedHCW Biologics finalizes license deal with Wugen – Longevity.Technology Empower Meds / November 22, 2025
